NCT01748942 Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer Status COMPLETED Phase NA
NCT01745640 Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14) Status COMPLETED Phase PHASE2
NCT01745588 Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01743755 Santeon-CAP; Dexamethasone in Community-acquired Pneumonia Status TERMINATED Phase PHASE4
NCT01736917 Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT01734928 Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01734161 Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections Status COMPLETED Phase PHASE4
NCT01734057 Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) Status WITHDRAWN Phase PHASE3
NCT01734044 rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP Status COMPLETED Phase PHASE3
NCT01731886 Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma Status COMPLETED Phase PHASE4
NCT01731795 Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome Status COMPLETED Phase PHASE4
NCT01728259 First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD Status TERMINATED Phase PHASE1
NCT01724892 Comparison the Effects of Dexamethasone and Loteprednol on Epithelial Healing Status COMPLETED Phase PHASE4
NCT01722305 Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma Status COMPLETED Phase PHASE1
NCT01714427 Validation of a Lung Inflammation Model in Healthy Volunteers by Radiological Tools and Glucocorticoid Treatment Status COMPLETED Phase NA
NCT01712789 Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01711528 Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01706666 Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT01700946 Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma Status COMPLETED Phase PHASE2
NCT01699412 Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease Status COMPLETED Phase PHASE3